Literature DB >> 16644435

Risk stratification in chronic heart failure: independent and incremental prognostic value of echocardiography and brain natriuretic peptide and its N-terminal fragment.

Christian Bruch1, Markus Rothenburger, Michael Gotzmann, Juergen Sindermann, Hans H Scheld, Günter Breithardt, Thomas Wichter.   

Abstract

BACKGROUND: It was the aim of this study to compare the prognostic impact of echocardiography and brain natriuretic peptide and its N-terminal fragment (NT-proBNP) in patients with chronic heart failure (CHF).
METHODS: In all, 73 patients with CHF underwent conventional 2-dimensional/Doppler echocardiography and Doppler tissue analysis of systolic, early and late diastolic mitral annular velocities. The mitral filling pattern was classified as restrictive or nonrestrictive. NT-proBNP measurements were carried out on a bench-top analyzer. A cardiac event (rehospitalization caused by worsening CHF, cardiac death, urgent cardiac transplantation) was defined as combined study end point.
RESULTS: During follow-up of 226 +/- 169 days, 27 patients had an event (rehospitalization because of CHF, n = 18; cardiac death, n = 7; urgent transplantation, n = 2). On multivariate Cox regression analysis, a restrictive filling pattern, NT-proBNP, the ratio of peak early diastolic mitral flow to mitral annular E' velocity were independent prognostic predictors. A risk stratification model based on the 3 strongest independent predictors separated groups into those with good, intermediate, and poor outcome (event-free survival of 78%, 46%, and 0%, respectively).
CONCLUSIONS: In patients with CHF, Doppler echocardiography, Doppler tissue imaging, and NT-proBNP provide independent and incremental prognostic information. A combined use of echocardiography and NT-proBNP may help to improve risk stratification in this patient population.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16644435     DOI: 10.1016/j.echo.2005.12.027

Source DB:  PubMed          Journal:  J Am Soc Echocardiogr        ISSN: 0894-7317            Impact factor:   5.251


  6 in total

1.  N-terminal pro-B-type natriuretic peptide and long-term mortality in non-ischaemic cardiomyopathy.

Authors:  Florian Krackhardt; Hans-Dirk Düngen; Tobias Daniel Trippel; Simone Inkrot; Verena Tscholl; Peter Schlattmann; Kathrin Kehrt; Wilhelm Haverkamp
Journal:  Wien Klin Wochenschr       Date:  2011-11-23       Impact factor: 1.704

Review 2.  BNP and NT-proBNP as prognostic markers in persons with chronic stable heart failure.

Authors:  Mark Oremus; Andrew Don-Wauchope; Robert McKelvie; Pasqualina L Santaguida; Stephen Hill; Cynthia Balion; Ronald Booth; Judy A Brown; Usman Ali; Amy Bustamam; Nazmul Sohel; Parminder Raina
Journal:  Heart Fail Rev       Date:  2014-08       Impact factor: 4.214

3.  Adiponectin is independently associated with NT-proBNP: The Multi-Ethnic Study of Atherosclerosis.

Authors:  M A Allison; M H Criqui; A S Maisel; L B Daniels; C K Roberts; J F Polak; M Cushman
Journal:  Nutr Metab Cardiovasc Dis       Date:  2015-04-25       Impact factor: 4.222

4.  The prognostic value of a new tissue Doppler parameter in patients with heart failure.

Authors:  Cristian Mornoş; Lucian Petrescu; Adina Ionac; Dragoş Cozma
Journal:  Int J Cardiovasc Imaging       Date:  2013-09-17       Impact factor: 2.357

Review 5.  Clinical applications of N-terminal pro B-type natriuretic peptide in heart failure and other cardiovascular diseases.

Authors:  Da-Rong Pu; Jun R Chiong; Qi-chang Zhou
Journal:  Heart Fail Rev       Date:  2010-07       Impact factor: 4.214

6.  A new tissue Doppler index to predict cardiac death in patients with heart failure.

Authors:  Cristian Mornos; Lucian Petrescu; Dragos Cozma; Adina Ionac
Journal:  Arq Bras Cardiol       Date:  2013-11-12       Impact factor: 2.000

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.